Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination therapy improved hair growth and thickness in people with androgenetic alopecia.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

uPA helps hair follicle cells grow.

Blebbistatin can reduce fibrosis by targeting myofibroblast contraction.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

Injecting a person's own fat into their scalp may help regrow hair and improve hair thickness in different types of hair loss.

SUN11602 and ONO-1301 could help in skin healing and creating artificial skin.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

The chitosan-peptide system helps cartilage regeneration using fat-derived cells.

Human hair keratin artificial tendon is a safe and effective tendon substitute.

Botulinum toxin A does not significantly improve hair density or thickness in androgenetic alopecia.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Plasma gel and PRP treatments improve skin and hair with minimal side effects.